Abstract:Autoimmune diseases are immune disorders characterized by T cell hyperactivity and B cell overstimulation leading to overproduction of autoantibodies. Although the pathogenesis of various autoimmune diseases remains to be elucidated, environmental factors have been thought to contribute to the initiation and maintenance of auto-respond inflammation. Toll-like receptors (TLRs) are pattern recognition receptors belonging to innate immunity that recognize and defend invading microorganisms. Besides these exogenous pathogen-associated molecular patterns, TLRs can also bind with damage-associated molecular patterns produced under strike or by tissue damage or cells apoptosis. It is believed that TLRs build a bridge between innate immunity and autoimmunity. There are five adaptors to TLRs including MyD88, TRIF, TIRAP/MAL, TRAM, and SARM. Upon activation, TLRs recruit specific adaptors to initiate the downstream signaling pathways leading to the production of inflammatory cytokines and chemokines. Under certain circumstances, ligation of TLRs drives to aberrant activation and unrestricted inflammatory responses, thereby contributing to the perpetuation of inflammation in autoimmune diseases. In the past, most studies focused on the intracellular TLRs, such as TLR3, TLR7, and TLR9, but recent studies reveal that cell surface TLRs, especially TLR2 and TLR4, also play an essential role in the development of autoimmune diseases and afford multiple therapeutic targets. In this review, we summarized the biological characteristics, signaling mechanisms of TLR2/4, the negative regulators of TLR2/4 pathway, and the pivotal function of TLR2/4 in the pathogenesis of autoimmune diseases including rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, Sjogren's syndrome, psoriasis, multiple sclerosis, and autoimmune diabetes.

Toll-like Receptor 4 Deficiency Ameliorates Experimental Autoimmune Neuritis by Downregulating Classically Activated Macrophages (M1)

Toll-Like Receptor 4 Promotes Th17 Lymphocyte Infiltration Via CCL25/CCR9 in Pathogenesis of Experimental Autoimmune Encephalomyelitis

Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders

Nr4a1 Plays a Crucial Modulatory Role in Th1/Th17 Cell Responses and CNS Autoimmunity

TLR2 and TLR4 in autoimmune diseases: a comprehensive review

Toll-like Receptor 4 Sirna Attenuates LPS-induced Secretion of Inflammatory Cytokines and Chemokines by Macrophages.

Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice.

Toll-like receptor 4: the potential therapeutic target for neuropathic pain]

Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems

TLR4 deficiency abrogated widespread tactile allodynia, but not widespread thermal hyperalgesia and trigeminal neuropathic pain after partial infraorbital nerve transection.

Reduced Cerebral Ischemia-Reperfusion Injury in Toll-like Receptor 4 Deficient Mice.

Toll‐like receptors control the accumulation of neutrophils in lymph nodes that expand CD4+ T cells during experimental autoimmune encephalomyelitis

Attenuated EAN in TNF-α Deficient Mice is Associated with an Altered Balance of M1/M2 Macrophages

Notch Ligand Delta-Like 4 Blockade Alleviates Experimental Autoimmune Encephalomyelitis by Promoting Regulatory T Cell Development

Cutting Edge: TLR3 Stimulation Suppresses Experimental Autoimmune Encephalomyelitis by Inducing Endogenous IFN-beta.

Transient receptor potential vanilloid 1 interacts with TLR4/CD14 signaling pathway in lipopolysaccharide-mediated inflammation in macrophages

TLR5-deficiency controls dendritic cell subset development in an autoimmune diabetes-susceptible model

Toll Like Receptor 4 Mediates Cell Death in a Mouse MPTP Model of Parkinson Disease

Toll-like receptor 4 signaling-mediated responses are critically engaged in optimal host protection against highly virulent Mycobacterium tuberculosis K infection

TLR4 activation is required for IL-17-induced multiple tissue inflammation and wasting in mice.

Dysfunctional monocytic toll-like receptor 4 signaling pathway and cognitive deficits in chronic schizophrenia patients with tardive dyskinesia